Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

14 vs 24 Weeks HCV Treatment to Genotype 2/3 Patients With Rapid Virological Response

NCT00308048 is registered in ClinicalTrials.gov with Ullevaal University Hospital as lead sponsor.

NCT NCT00308048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00308048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
14 vs 24 Weeks HCV Treatment to Genotype 2/3 Patients With Rapid Virological Response
Lead sponsor
Ullevaal University Hospital
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2004
Completion date
September 30, 2006
Enrollment
435
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c virus infection